Category: MAKO Surgical Corp.
Mako Surgical says it's settled 1 of 2 sets of lawsuits filed by shareholders ahead of its $1.65 billion buyout by Stryker Corp.
Company officials at Mako Surgical discuss the company's Q2 2013 earnings release. Mako posted Q3 losses of $21.3 million, or 45¢ per share, on sales of $22.8 million for the 3 months ended Sept. 30, 2013
Mako Surgical's sales drop and losses soar in the midst of its $1.65 billion buyout by Stryker, which compels Mako to withdraw its 2013 financial guidance.
Mako Surgical says it's closed its buyout of spinal implant maker Pipeline Biomedical Holdings ahead of its own acquisition by Stryker Corp.
Mako Surgical (NSDQ:MAKO) said it closed its buyout of partner Pipeline Biomedical Holdings in a cash/stock deal, ahead of its own, $1.7 billion acquisition by Stryker (NYSE:SYK).
Mako Surgical says it paid $2.5 million and issued another nearly 4 million shares to consummate its buyout of partner Pipeline Biomedical Holdings, which makes some of the implants used with its Rio robotic surgery device.
Stryker says it's agreed to pay $1.65 billion for robotic surgery company Mako Surgical, boosting share prices for Intuitive Surgical and other firms in the robot-guided surgery market.